[Antithrombotic prophylaxis in pregnancy].
Czestochowska
E
E
Klinika Chorób Wewnetrznych, Endokrynologii i Zaburzeń Hemostazy Instytutu Chorób Wewnetrznych AM w Gdańsku.
D001241:Aspirin / Q000008:administration & dosage; D005165:Factor V / Q000235:genetics; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D009154:Mutation; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology / Q000517:prevention & control*; D018455:Protein S Deficiency / Q000235:genetics; D013923:Thromboembolism / Q000235:genetics / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D005165:Factor V; D001241:Aspirin